• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 233/56 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Patent holdings for IPC class C07D 233/56

Total number of patents in this class: 207

10-year publication summary

20
18
23
7
8
7
12
4
4
1
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Gilead Sciences, Inc.
2134
12
BASF SE
21135
8
FUJIFILM Corporation
30010
7
Agency for Science, Technology and Research
3665
5
University of Maryland, Baltimore
1044
5
Bayer Cropscience AG
1957
4
Nippon Soda Co., Ltd.
888
4
sanofi-aventis
337
4
Janssen Pharmaceutica N.V.
3340
3
Alexion Pharmaceuticals, Inc.
645
3
NMD Pharma A/S
47
3
Sanofi
4161
3
Novartis AG
10494
2
Centre National de La Recherche Scientifique
10801
2
Murata Manufacturing Co., Ltd.
25214
2
Dow Technology Investments LLC
276
2
PRC-DeSoto International, Inc.
568
2
University of Florida Research Foundation, Inc.
4110
2
BioLab Sanus Farmaceutica Ltda.
47
2
Central Glass Company, Limited
1280
2
Other owners 130